Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy Infants

This study has been completed.
Sponsor:
Collaborator:
Center for Research and Production of Vaccines and Biologicals, Vietnam
Information provided by (Responsible Party):
Dang Duc Anh, National Institute of Hygiene and Epidemiology, Vietnam
ClinicalTrials.gov Identifier:
NCT01377571
First received: May 19, 2011
Last updated: June 30, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):